MedTrace Logo

Is There A LIfe for Drug Eluting Stent (DES) After Discontinuation of Clopidogrel

NCT01476020 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1240

Last updated 2011-11-22

No results posted yet for this study

Summary

The ITALIC PLUS Trial was designed with the objective of extending to other countries the enrollment of patients into the ITALIC trial initially conducted in France, in order to achieve statistical significance by pooling the data of both trials.

Conditions

  • Restenosis

Sponsors & Collaborators

  • Clinical Research Organization and study management

    collaborator UNKNOWN

  • Abbott Medical Devices

    collaborator INDUSTRY

  • Gilard, Martine

    lead INDIV

Principal Investigators

  • martine Gilard, MD,PhD · Brest University France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-07-31
Completion
2015-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01476020 on ClinicalTrials.gov